[1]
“Treatment Outcome of Remdesivir Compared to Favipiravir on Moderate Symptoms COVID-19”, AMEDJ, vol. 4, no. 1, pp. 19–24, Jul. 2023, doi: 10.15408/avicenna.v4i1.31132.